Topics

Suzhou Alphamab Co., Ltd. Company Profile

04:21 EDT 17th September 2019 | BioPortfolio

Alphamab, founded in 2009, is a leading biotechnology company focused on the discovery and development of innovative biologics therapeutics. With multiple in-house proprietary platforms in protein engineering, antibody screening and bispecifics, Alphamab and its subsidiaries have created a robust pipeline of over 20 innovative biologics programs in oncology and several other areas. Alphamab is striving to develop 1st-in-class or best-in-class medicine to address unmet medical needs globally.


News Articles [102 Associated News Articles listed on BioPortfolio]

Suzhou's Alphamab Oncology Approved to IPO on Hong Kong Exchange

Alphamab Oncology, which was spun out of Suzhou Alphamab last year, was approved to IPO in Hong Kong under the Exchange's pre-revenue rules. The bi-specifics company has eight oncology molecules in de...

Suzhou's Alphamab Closes $60 Million Series B for Biologic Oncology Portfolio

Alphamab Oncology of Suzhou closed a $60 million Series B led by Hudson Bay Capital Management to support its biologic oncology drug business. Using its experience in protein development, Alphamab is ...

Series B brings $60mm to Alphamab

Jiangsu Alphamab Biopharmaceuticals Co. Ltd. (Alphamab Oncology) raised $60mm through its Series B round. Hudson Bay Capital led and was joined by new investors including Adrian Cheng, as well as retu...

Week in Review: Three China Biopharmas Announce Plans for Shanghai/Hong Kong IPOs

Deals and Financings • HitGen of Chengdu, a small molecule discovery CRO with over 60 partnerships, was approved for a $97 million IPO on Shanghai's new STAR Exchange; • Shenzhen Chipscreen ...

July 15 Financial Quick Takes: RA raises $300M for new fund; plus Alphamab and Castle

May 28 Financial Quick Takes: Alphamab Oncology raises $60M; plus $180.5M for Panacea healthcare fund and more

Phillips-Medisize to showcase products at Drug Delivery and Digital Health at Suzhou Dialogue 2019 in China

Phillips-Medisize, a Molex company, announces a significant exhibiting and speaking presence at the Suzhou Dialogue conference, organized by the China National Pharmaceutical Packaging Association (CN...

CStone to Build Major R&D and Manufacturing Complex in Suzhou Park

CStone Pharma, a Suzhou oncology company, signed an agreement with Suzhou Industrial Park to build a 100,000 square meter facility that will house integrated R&D, pilot plant and commercial manufa...

Drugs and Medications [0 Results]

None

PubMed Articles [8 Associated PubMed Articles listed on BioPortfolio]

Development of microbial community-based index of biotic integrity to evaluate the wetland ecosystem health in Suzhou, China.

The development of microbial community-based biological indicators for assessing aquatic ecological status is urgently needed in heavily impaired regions, due to the local extinction of traditional in...

The Fifth Symposium on Innovative Polymers for Controlled Delivery (SIPCD 2018), September 14-17, 2018, Suzhou, China.

Procurement innovation for a circular economy of construction and demolition waste: Lessons learnt from Suzhou, China.

Amidst the global trend of advocating a circular economy, various nations and regions in recent years have started to explore innovative procurement models (e.g., Public Private Partnership [PPP]) in ...

Research Capacity and Research Training Needs of Clinical Nurses in Suzhou, China.

Several studies examined the research capacity of nurses in the United States and other countries. However, the research capacity of clinical nurses in China has not been systematically surveyed. Thus...

Risk Factors for Congenital Syphilis Transmitted from Mother to Infant - Suzhou, China, 2011-2014.

Mother-to-child transmission of syphilis remains a major global public health issue, and elimination of congenital syphilis is one of the millennium development goals of the World Health Organization ...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Deep Brain Stimulation of Nucleus Accumbens for Opioid Relapse Prevention

Nucleus accumbens plays important roles in the process of opiate addiction and initial of relapse after detoxification.According to the single-centered preliminary open-labeled prospective...

Bronchial Ablation for Treatment of Asthma (BATA) Trial

To evaluate the safety and efficacy of a bronchial radiofrequency ablation system (SyMap Medical (Suzhou) Ltd) in a population of subjects with severe asthma who are still symptomatic desp...

Companies [20 Associated Companies listed on BioPortfolio]

Suzhou Alphamab Co., Ltd.

Alphamab, founded in 2009, is a leading biotechnology company focused on the discovery and development of innovative biologics therapeutics. With multiple in-house proprietary pla...

SINOCHEM JIANGSU SUZHOU I/E CORP.

SINOCHEM JIANGSU SUZHOU I/E CORP. ESTABLISHED IN 1988, IS A SUBSIDIARY OF SINOCHEM AND A STATE-OWNED FOREIGH TRADE ENTERPRISE AUTHORISED BY THE CHINESE MINISTRY OF FOREIGH TRADE AND ECONOMIC C...

Suzhou Kaiyuan Minsheng Chemicals Technology Co.,Ltd

Suzhou Kaiyuan Minsheng Chemicals Technology Co., Ltd.(briefed as MSTC)is located in Sino-Singapore Suzhou Industrial Park, covering an area of 37,500 square meters excluding the factories. Integratin...

Suzhou No.5 Pharmaceutical Factory Co., Ltd.

Suzhou No.5 Pharmaceutical Factory was founded in 1962 for the production of API's and API intermediates. During the past 40 years the Company firmly established a strong presence in the pharmaceutica...

Dawnrays Pharmaceutical (Holdings) Ltd.

Dawnrays Pharmaceutical (Holdings) Ltd., founded on 8th December 1995 by a Hong Kong investor, is now being the parent company as a listed company in Hong Kong Stock Exchange Market since 7th Novembe...

More Information about "Suzhou Alphamab Co., Ltd." on BioPortfolio

We have published hundreds of Suzhou Alphamab Co., Ltd. news stories on BioPortfolio along with dozens of Suzhou Alphamab Co., Ltd. Clinical Trials and PubMed Articles about Suzhou Alphamab Co., Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Suzhou Alphamab Co., Ltd. Companies in our database. You can also find out about relevant Suzhou Alphamab Co., Ltd. Drugs and Medications on this site too.

Quick Search

Relevant Topics

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record